Loading data for IART — first visit, this takes a few seconds.
Integra LifeSciences Cor... (IART)
: IART
· Real-Time Price · USD
n/a
n/a (n/a)
At close: Invalid Date
17.24
+0.00%
After-hours: 4:10 PM
Integra LifeSciences Corporation (IART) Stock Price, Analysis & Data
No data available
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | 1.65B |
| Net Income (ttm) | -7.24M |
| Beta | 1.21 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | 6.62 |
| P/B (ttm) | 1.29 |
| P/S (ttm) | 0.81 |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | NaN |
| Avg. Volume (20D) | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a - n/a |
| 52-Week Range | n/a - n/a |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management d...
Industry Medical Devices
Sector Healthcare
IPO Date Aug 16, 1995
Employees 4,427
Stock Exchange NasdaqGS
Ticker Symbol IART
Website https://www.integralife.com
Financial Performance
In 2025, Integra LifeSciences's revenue was 1.64B, an increase of 1.53% compared to the previous year's 1.61B. Earnings were -516.47M, an increase of 7,337.7%.
Financial Statements